Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring

Iole Macchia1, Valentina La Sorsa2, Irene Ruspantini3

  • 1Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome 00161, Italy.

Insights

Standardising flow cytometry (FCM) assays is vital for personalised oncology. This study developed a harmonisation workflow reducing variability in multicentre clinical trials for immunological biomarker analysis.

Area of Science:

  • Immunology
  • Oncology
  • Clinical Trials

Background:

  • Personalised medicine in oncology requires standardised immunological assays.
  • Flow cytometry (FCM) is essential for immunomonitoring in clinical trials.
  • Harmonisation of FCM methods is crucial for comparable multicentre data.

Purpose of the Study:

  • To design a harmonisation workflow for FCM assays.
  • To address intra- and interoperator variabilities in multicentre projects.
  • To improve data comparability for immunological biomarkers in oncology.

Main Methods:

  • Multicentre harmonisation of a multiparametric FCM panel involving thirteen operators.
  • Use of a dried antibody mixture targeting naïve/memory T cells.
  • Distribution of samples, reagents, and Standard Operating Procedures (SOPs) to participants.
  • Centralised data analysis by the coordinating centre (Istituto Superiore di Sanità, ISS).

Main Results:

  • Harmonised and reproducible FCM results were achieved.
  • Sharing experimental set-up and procedures reduced cross-centre variability.
  • Centralised data analysis significantly reduced variability, especially for naïve/memory T cell subsets in whole blood samples.

Conclusions:

  • The developed workflow is suitable for harmonising FCM assays in multicentre settings.
  • High-quality data can be generated for evaluating immunological markers.
  • This approach supports the selection of better therapeutic options in cancer immunotherapy.
Abstract

Related Concept Videos